Skip to main content

Table 2 Retail prices of one adult equivalent treatment dose (US$)

From: Determinants of price setting decisions on anti-malarial drugs at retail shops in Cambodia

Anti-malarial categories formulation

Retailer categories

All N = 382

Pharmacies/ Clinical pharmacies N = 77

Drug stores N = 75

Mobile providers N = 101

Grocery stores N = 57

Village shops N = 72

ACT

(n)

(454)

(130)

(101)

(106)

(53)

(64)

All were tablets

Median

1.18

1.18

1.18

1.65

1.11

1.55

IQR

0.94–1.18

0.71–1.18

0.94–1.18

1.18–2.15

0.71–1.65

1.06–2.12

AMT

(n)

(186)

(34)

(40)

(46)

(29)

(37)

All

Median

4.52

3.61

4.52

4.52

3.61

4.52

 

IQR

3.01–12.71

2.44–3.62

2.82–4.52

3.39–22.60

3.01–4.52

3.62–4.52

AMT

(n)

(129)

(15)

(31)

(26)

(25)

(32)

Tablet

Median

3.62

2.64

3.16

3.77

3.62

4.52

 

IQR

2.64–3.61

0.00–2.64

2.64–3.16

2.26–4.52

3.01–4.52

3.62–4.52

AMT

(n)

(57)

(19)

(9)

(20)

(4)

(5)

Injectable

Median

22.60

15.10

19.80

22.60

22.60

28.25

 

IQR

15.06–26.36

11.30–15.10

18.83–19.77

16.94–28.24

18.83–22.60

28.25–28.25

nAMT

(n)

(88)

(22)

(16)

(22)

(13)

(15)

All

Median

0.46

0.23

0.23

7.41

0.46

1.18

 

IQR

0.23–7.41

0.08–0.23

0.23–0.23

0.46–9.88

0.34–0.46

0.46–11.86

nAMT

(n)

(68)

(22)

(13)

(10)

(10)

(13)

Tablet

Median

0.41

0.23

0.23

0.46

0.46

0.68

 

IQR

0.23–0.41

0.08–0.23

0.23–0.23

3.41–0.46

0.23–0.46

0.35–11.86

nAMT

(n)

(20)

(0)

(3)

(12)

(3)

(2)

Injectable

Median

9.89

-

14.83

9.89

5.93

17.30

 

IQR

7.41–14.83

 

14.83–14.83

7.41–12.36

3.95–12.36

9.88–17.30

  1. ACT is artemisinin combination therapy; AMT is artemisinin monotherapy; nAMT is non-artemisinin monotherapy; (n) is number of product observations; N is number of retailers for whom information was available; IQR is inter-quartile range. “-“drug category not stocked